Adiponectin oligomers as potential indicators of adipose tissue improvement in obese subjects
ObjectiveAdiponectin is an adipocytokine that exerts beneficial effects on obesity and related disorders by two receptors (ADIPORs). Adiponectin is produced as a monomer that circulates in serum as different oligomers. The oligomerization state and the tissue expression of adiponectin and ADIPORs ar...
Saved in:
Published in | European journal of endocrinology Vol. 169; no. 1; pp. 37 - 43 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Bristol
BioScientifica
01.07.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ObjectiveAdiponectin is an adipocytokine that exerts beneficial effects on obesity and related disorders by two receptors (ADIPORs). Adiponectin is produced as a monomer that circulates in serum as different oligomers. The oligomerization state and the tissue expression of adiponectin and ADIPORs are linked to its biological activities. In this study, the levels of total adiponectin and its oligomers were evaluated in relation to obesity and surgical weight loss. The expression of adiponectin and ADIPORs was analyzed in visceral and subcutaneous adipose tissues of obese patients.Design and methodsIn 25 obese patients and 44 age- and sex-matched controls, the serum levels of adiponectin and its oligomers were measured and compared by ELISA, western blotting, and gel filtration. The expression of adiponectin and ADIPORs in both adipose tissues was evaluated by real-time quantitative PCR and western blotting.ResultsThe amount of each adiponectin oligomer, including the monomer, increases after weight loss. The reduced circulating levels of adiponectin and its oligomers are not associated with the adipose tissue depot-specific expression of adiponectin and ADIPORs.ConclusionsOur results suggest that in patients, adiposity is associated with the serum concentrations of adiponectin and its oligomers but not with adipose tissue depot-specific expression of adiponectin and ADIPORs. In particular, the increase in adiponectin monomer levels could probably be related to the improvement of the whole-body energy metabolism then being involved in the improvement of adipose tissue function after weight loss. This work indicates the importance of assessing the whole adiponectin oligomeric profile as further potential indicators of adipose tissue functions in obesity. |
---|---|
AbstractList | Adiponectin is an adipocytokine that exerts beneficial effects on obesity and related disorders by two receptors (ADIPORs). Adiponectin is produced as a monomer that circulates in serum as different oligomers. The oligomerization state and the tissue expression of adiponectin and ADIPORs are linked to its biological activities. In this study, the levels of total adiponectin and its oligomers were evaluated in relation to obesity and surgical weight loss. The expression of adiponectin and ADIPORs was analyzed in visceral and subcutaneous adipose tissues of obese patients.OBJECTIVEAdiponectin is an adipocytokine that exerts beneficial effects on obesity and related disorders by two receptors (ADIPORs). Adiponectin is produced as a monomer that circulates in serum as different oligomers. The oligomerization state and the tissue expression of adiponectin and ADIPORs are linked to its biological activities. In this study, the levels of total adiponectin and its oligomers were evaluated in relation to obesity and surgical weight loss. The expression of adiponectin and ADIPORs was analyzed in visceral and subcutaneous adipose tissues of obese patients.In 25 obese patients and 44 age- and sex-matched controls, the serum levels of adiponectin and its oligomers were measured and compared by ELISA, western blotting, and gel filtration. The expression of adiponectin and ADIPORs in both adipose tissues was evaluated by real-time quantitative PCR and western blotting.DESIGN AND METHODSIn 25 obese patients and 44 age- and sex-matched controls, the serum levels of adiponectin and its oligomers were measured and compared by ELISA, western blotting, and gel filtration. The expression of adiponectin and ADIPORs in both adipose tissues was evaluated by real-time quantitative PCR and western blotting.The amount of each adiponectin oligomer, including the monomer, increases after weight loss. The reduced circulating levels of adiponectin and its oligomers are not associated with the adipose tissue depot-specific expression of adiponectin and ADIPORs.RESULTSThe amount of each adiponectin oligomer, including the monomer, increases after weight loss. The reduced circulating levels of adiponectin and its oligomers are not associated with the adipose tissue depot-specific expression of adiponectin and ADIPORs.Our results suggest that in patients, adiposity is associated with the serum concentrations of adiponectin and its oligomers but not with adipose tissue depot-specific expression of adiponectin and ADIPORs. In particular, the increase in adiponectin monomer levels could probably be related to the improvement of the whole-body energy metabolism then being involved in the improvement of adipose tissue function after weight loss. This work indicates the importance of assessing the whole adiponectin oligomeric profile as further potential indicators of adipose tissue functions in obesity.CONCLUSIONSOur results suggest that in patients, adiposity is associated with the serum concentrations of adiponectin and its oligomers but not with adipose tissue depot-specific expression of adiponectin and ADIPORs. In particular, the increase in adiponectin monomer levels could probably be related to the improvement of the whole-body energy metabolism then being involved in the improvement of adipose tissue function after weight loss. This work indicates the importance of assessing the whole adiponectin oligomeric profile as further potential indicators of adipose tissue functions in obesity. Adiponectin is an adipocytokine that exerts beneficial effects on obesity and related disorders by two receptors (ADIPORs). Adiponectin is produced as a monomer that circulates in serum as different oligomers. The oligomerization state and the tissue expression of adiponectin and ADIPORs are linked to its biological activities. In this study, the levels of total adiponectin and its oligomers were evaluated in relation to obesity and surgical weight loss. The expression of adiponectin and ADIPORs was analyzed in visceral and subcutaneous adipose tissues of obese patients. In 25 obese patients and 44 age- and sex-matched controls, the serum levels of adiponectin and its oligomers were measured and compared by ELISA, western blotting, and gel filtration. The expression of adiponectin and ADIPORs in both adipose tissues was evaluated by real-time quantitative PCR and western blotting. The amount of each adiponectin oligomer, including the monomer, increases after weight loss. The reduced circulating levels of adiponectin and its oligomers are not associated with the adipose tissue depot-specific expression of adiponectin and ADIPORs. Our results suggest that in patients, adiposity is associated with the serum concentrations of adiponectin and its oligomers but not with adipose tissue depot-specific expression of adiponectin and ADIPORs. In particular, the increase in adiponectin monomer levels could probably be related to the improvement of the whole-body energy metabolism then being involved in the improvement of adipose tissue function after weight loss. This work indicates the importance of assessing the whole adiponectin oligomeric profile as further potential indicators of adipose tissue functions in obesity. ObjectiveAdiponectin is an adipocytokine that exerts beneficial effects on obesity and related disorders by two receptors (ADIPORs). Adiponectin is produced as a monomer that circulates in serum as different oligomers. The oligomerization state and the tissue expression of adiponectin and ADIPORs are linked to its biological activities. In this study, the levels of total adiponectin and its oligomers were evaluated in relation to obesity and surgical weight loss. The expression of adiponectin and ADIPORs was analyzed in visceral and subcutaneous adipose tissues of obese patients.Design and methodsIn 25 obese patients and 44 age- and sex-matched controls, the serum levels of adiponectin and its oligomers were measured and compared by ELISA, western blotting, and gel filtration. The expression of adiponectin and ADIPORs in both adipose tissues was evaluated by real-time quantitative PCR and western blotting.ResultsThe amount of each adiponectin oligomer, including the monomer, increases after weight loss. The reduced circulating levels of adiponectin and its oligomers are not associated with the adipose tissue depot-specific expression of adiponectin and ADIPORs.ConclusionsOur results suggest that in patients, adiposity is associated with the serum concentrations of adiponectin and its oligomers but not with adipose tissue depot-specific expression of adiponectin and ADIPORs. In particular, the increase in adiponectin monomer levels could probably be related to the improvement of the whole-body energy metabolism then being involved in the improvement of adipose tissue function after weight loss. This work indicates the importance of assessing the whole adiponectin oligomeric profile as further potential indicators of adipose tissue functions in obesity. |
Author | Pilone, Vincenzo Buono, Pasqualina Monaco, Maria Ludovica Nardelli, Carmela Capasso, Mario Daniele, Aurora De Rosa, Anna Forestieri, Pietro |
Author_xml | – sequence: 1 givenname: Anna surname: De Rosa fullname: De Rosa, Anna – sequence: 2 givenname: Maria Ludovica surname: Monaco fullname: Monaco, Maria Ludovica – sequence: 3 givenname: Mario surname: Capasso fullname: Capasso, Mario – sequence: 4 givenname: Pietro surname: Forestieri fullname: Forestieri, Pietro – sequence: 5 givenname: Vincenzo surname: Pilone fullname: Pilone, Vincenzo – sequence: 6 givenname: Carmela surname: Nardelli fullname: Nardelli, Carmela – sequence: 7 givenname: Pasqualina surname: Buono fullname: Buono, Pasqualina – sequence: 8 givenname: Aurora surname: Daniele fullname: Daniele, Aurora |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27517301$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23612446$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1r3DAURUVJSGYmWXVfvCkUipOnD3vs5RCmbcJANglkE4QsPxUF25r6yYH8-8pkQqGErCSkc88Tukt2NIQBGfvM4YIXEi63N9uci5yDrD-xBVfrOi8r-XDEFlCBylWp5ClbEj0B8LSHE3YqZMmFUuWCPW5av08-G_2Qhc7_Dj2OlBnK9iHiEL3pMj-03poY0nlwmZkDhFn0RBNmvt-P4Rn7xGazosF0R1PzlJR0xo6d6QjPD-uK3f_Y3l39yne3P6-vNru8UWId81JChdIgr-vW1kapqoDWCgEtl1hWYK0rDGJlgWNTFw5r1VaNU1DwtTOVkCv27dWb3vJnQoq692Sx68yAYSLNZVlAIUrJE_rlgE5Nj63ej74344t--5IEfD0Ahqzp3GgG6-kft05DJcwi_srZMRCN6LT10UQfhjga32kOeq5Hp3o0F3quJ2W-_5d5075PHyY0PpD1cxsuFfFh5i-7vaC- |
CitedBy_id | crossref_primary_10_1016_j_numecd_2014_10_010 crossref_primary_10_1186_s40348_023_00170_6 crossref_primary_10_26508_lsa_202302228 crossref_primary_10_3390_nu13061848 crossref_primary_10_3390_ijms251910865 crossref_primary_10_3390_molecules200917339 crossref_primary_10_1155_2014_658913 crossref_primary_10_1002_ptr_8340 crossref_primary_10_1111_cge_13509 crossref_primary_10_1111_cts_13401 crossref_primary_10_7868_S0869813918090010 crossref_primary_10_1002_oby_21563 crossref_primary_10_1016_j_domaniend_2015_05_001 crossref_primary_10_20945_2359_3997000000307 crossref_primary_10_1016_j_prostaglandins_2021_106585 crossref_primary_10_3390_ijerph17082855 crossref_primary_10_1016_j_cyto_2016_12_018 crossref_primary_10_3803_EnM_2015_30_3_326 crossref_primary_10_3390_cells8101134 crossref_primary_10_1016_j_bbrc_2018_03_213 crossref_primary_10_1016_j_tem_2020_12_001 crossref_primary_10_1007_s40496_021_00295_5 crossref_primary_10_1111_cen_13372 crossref_primary_10_4103_jdmimsu_jdmimsu_477_21 crossref_primary_10_1016_j_obmed_2019_100148 crossref_primary_10_1371_journal_pone_0133496 crossref_primary_10_1007_s12011_020_02100_3 crossref_primary_10_3389_fcvm_2020_583175 crossref_primary_10_1016_j_pupt_2016_07_008 crossref_primary_10_1016_j_bcp_2014_12_001 crossref_primary_10_1016_j_biochi_2015_12_008 crossref_primary_10_1007_s11010_022_04356_w crossref_primary_10_1177_20587384211015034 crossref_primary_10_1038_s41380_018_0102_9 crossref_primary_10_3390_jcm8050599 crossref_primary_10_23736_S0022_4707_20_10498_5 crossref_primary_10_1016_j_peptides_2014_11_007 crossref_primary_10_3389_fneur_2021_686398 crossref_primary_10_1007_s10557_020_07136_0 crossref_primary_10_3390_jcm9103327 crossref_primary_10_1007_s11695_014_1528_z crossref_primary_10_2147_DMSO_S405476 crossref_primary_10_1002_cbf_3767 crossref_primary_10_1016_j_lfs_2019_116687 crossref_primary_10_14374_HFS_2014_22_2_063 crossref_primary_10_1007_s11130_021_00906_7 crossref_primary_10_1016_j_biomaterials_2019_119281 crossref_primary_10_1016_j_cmet_2017_07_020 crossref_primary_10_3390_nu14122484 crossref_primary_10_1016_j_cyto_2016_03_002 crossref_primary_10_1111_obr_12674 crossref_primary_10_1177_1010428317695020 crossref_primary_10_37442_fme_2023_4_13 crossref_primary_10_15429_jkomor_2015_15_1_9 crossref_primary_10_1159_000502689 crossref_primary_10_1080_09637486_2020_1802580 crossref_primary_10_1136_bmjopen_2021_059642 crossref_primary_10_14374_HFS_2014_22_2_105 crossref_primary_10_1097_MD_0000000000000250 crossref_primary_10_1113_JP278732 crossref_primary_10_2174_1381612827666210303143442 crossref_primary_10_3389_fendo_2024_1382241 crossref_primary_10_3389_fimmu_2021_770066 crossref_primary_10_3390_biom14020221 crossref_primary_10_3390_cancers12061408 crossref_primary_10_3390_nu5104115 crossref_primary_10_1039_D3BM00619K crossref_primary_10_1007_s11055_019_00890_1 crossref_primary_10_1089_jmf_2021_0014 crossref_primary_10_3390_ijms21114184 |
Cites_doi | 10.1038/sj.ijo.0803676 10.1515/JPM.2009.128 10.1016/j.jaci.2007.10.018 10.1038/ijo.2008.243 10.1159/000172976 10.1007/s11695-011-0374-5 10.1074/jbc.M311113200 10.1111/j.1463-1326.2008.00899.x 10.1530/EJE-11-0537 10.1177/1479164111407784 10.1159/000339574 10.1007/s00125-006-0452-8 10.1172/JCI29126 10.1038/oby.2006.5 10.1016/j.mehy.2011.07.063 10.1111/j.1365-2265.2008.03519.x 10.1038/oby.2007.627 10.1016/S0026-0495(03)00092-1 10.1074/jbc.M309469200 10.1007/s00125-012-2598-x 10.1210/er.2005-0005 10.1038/sj.ijo.0802367 10.2337/dc05-1801 10.1016/j.yjmcc.2007.10.018 10.1210/en.2004-1096 10.1038/oby.2008.275 10.1111/j.1365-2362.2008.02028.x 10.1007/s00795-007-0364-9 10.1073/pnas.98.4.2005 10.1016/j.biocel.2011.12.016 10.1016/j.amjcard.2007.03.062 10.1038/ijo.2011.223 10.1073/pnas.222657499 10.1038/nrgastro.2011.112 |
ContentType | Journal Article |
Copyright | 2013 European Society of Endocrinology 2014 INIST-CNRS |
Copyright_xml | – notice: 2013 European Society of Endocrinology – notice: 2014 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1530/EJE-12-1039 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
DocumentTitleAlternate | Modulation in ACRP30 pattern after weight loss |
EISSN | 1479-683X |
EndPage | 43 |
ExternalDocumentID | 23612446 27517301 10_1530_EJE_12_1039 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 2WC 3O- 4.4 53G 5GY 5RE 5VS 5WD AABZA AACZT AAPGJ AAPXW AARHZ AAVAP AAWDT ABLYK ABMNT ABNHQ ABOCM ABPQP ABPTD ABSGY ABSQV ABWST ABXVV ACFRR ACGFO ACNCT ACPRK ACUTJ ADBBV ADDZX ADIPN ADQBN ADVEK AENEX AFFNX AFGWE AFHIN AFYAG AGQXC AGUTN AI. AJEEA ALMA_UNASSIGNED_HOLDINGS ANFBD APJGH AQVPL BAWUL BCRHZ BTFSW C1A CS3 DIK DU5 E3Z EBS EJD EMOBN F9R GX1 HZ~ IL9 INIJC J5H KOP KQ8 L7B O9- OAUYM OBOKY OCZFY OJZSN OK1 OPAEJ OVD OWPYF P2P RHF ROX SJN TBS TCN TEORI TMA TR2 VH1 W8F WOQ X7M ZA5 ZGI ZXP AAUAY AAYXX ABDFA ABEJV ABGNP ABIME ABJNI ABPIB ABQNK ABVGC ABXZS ADGKP ADMTO ADNBA ADVOB AEMQT AFXAL AGORE AHGBF AHMMS AJBYB AJNCP ALXQX ATGXG CITATION H13 OBFPC IQODW NU- CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-b427t-6308e3ae199dc9a44850dc220d13e680ccf5aee8c01eb95fe94d8bf40517fa823 |
ISSN | 0804-4643 1479-683X |
IngestDate | Thu Jul 10 23:02:50 EDT 2025 Thu Apr 03 06:56:58 EDT 2025 Mon Jul 21 09:16:31 EDT 2025 Tue Jul 01 04:13:24 EDT 2025 Thu Apr 24 23:09:01 EDT 2025 Tue Apr 02 06:25:38 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Human Obesity Improvement Adipose tissue Nutrition disorder Endocrinology Nutritional status Indicator Adiponectin |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-b427t-6308e3ae199dc9a44850dc220d13e680ccf5aee8c01eb95fe94d8bf40517fa823 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://dx.doi.org/10.1530/EJE-12-1039 |
PMID | 23612446 |
PQID | 1365052631 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1365052631 pubmed_primary_23612446 pascalfrancis_primary_27517301 crossref_citationtrail_10_1530_EJE_12_1039 crossref_primary_10_1530_EJE_12_1039 bioscientifica_primary_10_1530_EJE_12_1039 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-07-01 |
PublicationDateYYYYMMDD | 2013-07-01 |
PublicationDate_xml | – month: 07 year: 2013 text: 2013-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Bristol |
PublicationPlace_xml | – name: Bristol – name: England |
PublicationTitle | European journal of endocrinology |
PublicationTitleAlternate | Eur J Endocrinol |
PublicationYear | 2013 |
Publisher | BioScientifica |
Publisher_xml | – name: BioScientifica |
References | Swarbrick (29_22770054) 2006; 49 Daniele (31_32654707) 2008; 53 (11_45944639) 2011; 8 Fruebis (16_11049513) 2001; 98 Benedix (34_39261896) 2011; 21 (28_45944648) 2008; 10 (4_43637584) 2007; 40 Fantuzzi (14_30446685) 2008; 121 (21_27161693) 2003; 27 Lin (24_41066918) 2012; 78 (7_40854776) 2011; 165 Kadowaki (3_22334027) 2006; 116 Kadowaki (2_18862708) 2005; 26 (15_45944640) 2009; 23 (5_19565533) 2003; 278 (27_45944647) 2011; 8 (9_19566779) 2004; 279 (35_45944649) 2007; 15 (36_19674547) 2002; 99 (12_18616503) 2005; 146 (20_45944643) 2012; 5 Bobbert (13_30495224) 2008; 44 (17_45944641) 2012; 308 (26_45944646) 2006; 14 (6_45944638) 2012; 44 Nannipieri (25_29925869) 2007; 31 Kaser (33_32697445) 2008; 38 (18_45944642) 2012; 36 Inoue (8_29256824) 2007; 100 Almer (37_41077750) 2011; 5 (22_45944644) 2003; 52 (23_45944645) 2008; 16 (1_45198214) 2012; 55 Hara (32_22164125) 2006; 29 (19_44859151) 2008; 32 Mazaki-Tovi (30_35083358) 2009; 37 Bobbert (10_35598005) 2009; 71 |
References_xml | – volume: 308 start-page: 150 issn: 0098-7484 year: 2012 ident: 17_45944641 publication-title: JAMA – volume: 31 start-page: 1843 issn: 0307-0565 issue: 12 year: 2007 ident: 25_29925869 publication-title: International journal of obesity doi: 10.1038/sj.ijo.0803676 – volume: 37 start-page: 623 issn: 0300-5577 issue: 6 year: 2009 ident: 30_35083358 publication-title: Journal of perinatal medicine doi: 10.1515/JPM.2009.128 – volume: 121 start-page: 326 issn: 1097-6825 issue: 2 year: 2008 ident: 14_30446685 publication-title: Journal of Allergy and Clinical Immunology doi: 10.1016/j.jaci.2007.10.018 – volume: 32 start-page: S83 issn: 0307-0565 year: 2008 ident: 19_44859151 publication-title: International journal of obesity doi: 10.1038/ijo.2008.243 – volume: 53 start-page: 155 issn: 0250-6807 issue: 3-4 year: 2008 ident: 31_32654707 publication-title: Annals of nutrition & metabolism doi: 10.1159/000172976 – volume: 21 start-page: 616 issn: 0960-8923 issue: 5 year: 2011 ident: 34_39261896 publication-title: Obesity surgery : the official journal of the American Society for Bariatric Surgery and of the Obesity Surgery Society of Australia and New Zealand doi: 10.1007/s11695-011-0374-5 – volume: 279 start-page: 12152 issn: 0021-9258 issue: 13 year: 2004 ident: 9_19566779 publication-title: Journal of Biological Chemistry doi: 10.1074/jbc.M311113200 – volume: 10 start-page: 1266 year: 2008 ident: 28_45944648 publication-title: DIABETES OBESITY METABOLISM doi: 10.1111/j.1463-1326.2008.00899.x – volume: 165 start-page: 969 issn: 0804-4643 issue: 6 year: 2011 ident: 7_40854776 publication-title: European Journal of Endocrinology doi: 10.1530/EJE-11-0537 – volume: 8 start-page: 190 year: 2011 ident: 11_45944639 publication-title: DIABETES VASCULAR DISEASE RESEARCH doi: 10.1177/1479164111407784 – volume: 5 start-page: 452 year: 2012 ident: 20_45944643 publication-title: OBESITY FACTS doi: 10.1159/000339574 – volume: 49 start-page: 2552 issn: 0012-186X issue: 11 year: 2006 ident: 29_22770054 publication-title: Diabetologia doi: 10.1007/s00125-006-0452-8 – volume: 116 start-page: 1784 issn: 0021-9738 issue: 7 year: 2006 ident: 3_22334027 publication-title: Journal of Clinical Investigation doi: 10.1172/JCI29126 – volume: 23 start-page: 7 year: 2009 ident: 15_45944640 publication-title: CELL COMMUNICATION AND SIGNALING – volume: 14 start-page: 28 year: 2006 ident: 26_45944646 publication-title: OBESITY doi: 10.1038/oby.2006.5 – volume: 78 start-page: 75 issn: 0306-9877 issue: 1 year: 2012 ident: 24_41066918 publication-title: Medical hypotheses doi: 10.1016/j.mehy.2011.07.063 – volume: 71 start-page: 507 issn: 0300-0664 issue: 4 year: 2009 ident: 10_35598005 publication-title: Clinical endocrinology doi: 10.1111/j.1365-2265.2008.03519.x – volume: 15 start-page: 1172 year: 2007 ident: 35_45944649 publication-title: OBESITY doi: 10.1038/oby.2007.627 – volume: 52 start-page: 958 year: 2003 ident: 22_45944644 publication-title: METABOLISM CLINICAL AND EXPERIMENTAL doi: 10.1016/S0026-0495(03)00092-1 – volume: 278 start-page: 50810 issn: 0021-9258 issue: 50 year: 2003 ident: 5_19565533 publication-title: Journal of Biological Chemistry doi: 10.1074/jbc.M309469200 – volume: 55 start-page: 2319 issn: 0012-186X year: 2012 ident: 1_45198214 publication-title: Diabetologia doi: 10.1007/s00125-012-2598-x – volume: 26 start-page: 439 issn: 0163-769X issue: 3 year: 2005 ident: 2_18862708 publication-title: Endocrine Reviews doi: 10.1210/er.2005-0005 – volume: 27 start-page: 896 year: 2003 ident: 21_27161693 publication-title: INTERNATIONAL JOURNAL OF OBESITY AND RELATED METABOLIC DISORDERS doi: 10.1038/sj.ijo.0802367 – volume: 29 start-page: 1357 issn: 0149-5992 issue: 6 year: 2006 ident: 32_22164125 publication-title: Diabetes Care doi: 10.2337/dc05-1801 – volume: 44 start-page: 388 issn: 0022-2828 issue: 2 year: 2008 ident: 13_30495224 publication-title: Journal of molecular and cellular cardiology doi: 10.1016/j.yjmcc.2007.10.018 – volume: 5 start-page: 95 issn: 1177-5475 year: 2011 ident: 37_41077750 – volume: 146 start-page: 790 issn: 0013-7227 issue: 2 year: 2005 ident: 12_18616503 publication-title: Endocrinology doi: 10.1210/en.2004-1096 – volume: 16 start-page: 1869 year: 2008 ident: 23_45944645 publication-title: OBESITY doi: 10.1038/oby.2008.275 – volume: 38 start-page: 827 issn: 0014-2972 issue: 11 year: 2008 ident: 33_32697445 publication-title: European journal of clinical investigation doi: 10.1111/j.1365-2362.2008.02028.x – volume: 40 start-page: 115 year: 2007 ident: 4_43637584 publication-title: MEDICAL MOLECULAR MORPHOLOGY doi: 10.1007/s00795-007-0364-9 – volume: 98 start-page: 2005 issn: 0027-8424 issue: 4 year: 2001 ident: 16_11049513 publication-title: PNAS doi: 10.1073/pnas.98.4.2005 – volume: 44 start-page: 563 year: 2012 ident: 6_45944638 publication-title: INTERNATIONAL JOURNAL OF BIOCHEMISTRY CELL BIOLOGY doi: 10.1016/j.biocel.2011.12.016 – volume: 100 start-page: 569 issn: 0002-9149 issue: 4 year: 2007 ident: 8_29256824 publication-title: The American journal of cardiology doi: 10.1016/j.amjcard.2007.03.062 – volume: 36 start-page: 1360 issn: 0307-0565 year: 2012 ident: 18_45944642 publication-title: International journal of obesity doi: 10.1038/ijo.2011.223 – volume: 99 start-page: 16309 issn: 0027-8424 issue: 25 year: 2002 ident: 36_19674547 publication-title: PNAS doi: 10.1073/pnas.222657499 – volume: 8 start-page: 429 year: 2011 ident: 27_45944647 publication-title: NATURE REVIEWS GASTROENTEROLOGY AND HEPATOLOGY doi: 10.1038/nrgastro.2011.112 |
SSID | ssj0016430 |
Score | 2.3593695 |
Snippet | ObjectiveAdiponectin is an adipocytokine that exerts beneficial effects on obesity and related disorders by two receptors (ADIPORs). Adiponectin is produced as... Adiponectin is an adipocytokine that exerts beneficial effects on obesity and related disorders by two receptors (ADIPORs). Adiponectin is produced as a... |
SourceID | proquest pubmed pascalfrancis crossref bioscientifica |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 37 |
SubjectTerms | Adiponectin - blood Adiponectin - genetics Adiponectin - metabolism Adipose Tissue - metabolism Adult Bariatric Surgery Biological and medical sciences Biomarkers - blood Blotting, Western Body Mass Index Case-Control Studies Chromatography, Gel Clinical Study Endocrinopathies Female Fundamental and applied biological sciences. Psychology Heparin, Low-Molecular-Weight - blood Humans Male Medical sciences Metabolic diseases Middle Aged Obesity Obesity, Morbid - blood Obesity, Morbid - metabolism Obesity, Morbid - surgery Real-Time Polymerase Chain Reaction Receptors, Adiponectin - blood RNA, Messenger - isolation & purification Vertebrates: endocrinology Weight Loss |
Title | Adiponectin oligomers as potential indicators of adipose tissue improvement in obese subjects |
URI | http://dx.doi.org/10.1530/EJE-12-1039 https://www.ncbi.nlm.nih.gov/pubmed/23612446 https://www.proquest.com/docview/1365052631 |
Volume | 169 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9RAEF-0glhUtPVRH2WF4geP1M07-XjqSalWVFroFwm7ya4E2uxxyQn61zuzmye2Yv0SjtzskuxvMjszOw9C9lSEmxoTDgsUGChBqhzOIriEifAZD2VoivocfYoOToLD0_B0cOaY7JJG7Oe_Lswr-R9U4R7gilmyV0C2nxRuwG_AF66AMFz_CeN5US51hSILlL6z8rtGJzR2jlnqBqOATEENPIgxLXXMiT8MqOWsMcuNKZIrbQqGm0YBWkj4r14L9M3Ul_rsW_1VVoUGkTP1y7-Ts6-6tr7aqupFPkgOkLxtblDJZx_Xhf4xjhKCLRvWqiPQw96IrUPKNh3-cymblR77KbBnRDz2U7wptZFWJgKKj6UcC5wgsrWa9qWVwkGcOlFiGgUPYtq2dJnwoxW6tmpMu33bif7YGEIfIykXhwsMRcHj7-vkhgeWBTa9-PBlOHiCBzFuue6p2pROGP56NHiT3BGlLTZq32ei1dyGJYMPTNnOKJebLkaFOb5H7ra2B51bRrpPrslqi2zPK2CP85_0JTXRwAbOLXLzqA262CbfRmxGezajvKY9m9GBzahWtGUzatmMjtiM4hTIZrRjswfk5P3i-O2B03blcETgxY0T-SyRPpdumhZ5ysG8D1mRex4rXF9GCctzFXIpk5y5UqQYyxgUiVABFoNTPPH8h2Sjgod-TGicM9A2XeVJMBxilguuZMHTCOgKX4Rsh7yaLnO2tCVYMjRdAZMMMMlcL0NMgLiDIMvb-vbYZuXsYuK9nvivc-5OsOxpvRjeBvbGHfKiAzcDuYyHbbySel1nGD6KtZR8oHlkUR9G-xGq1dGTq7zfU3Jr-KyekY1mtZbPQSFuxK5h4d8sGbsX |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adiponectin+oligomers+as+potential+indicators+of+adipose+tissue+improvement+in+obese+subjects&rft.jtitle=European+journal+of+endocrinology&rft.au=De+Rosa%2C+Anna&rft.au=Monaco%2C+Maria+Ludovica&rft.au=Capasso%2C+Mario&rft.au=Forestieri%2C+Pietro&rft.date=2013-07-01&rft.pub=BioScientifica&rft.issn=0804-4643&rft.eissn=1479-683X&rft.volume=169&rft.issue=1&rft.spage=37&rft.epage=43&rft_id=info:doi/10.1530%2FEJE-12-1039 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0804-4643&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0804-4643&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0804-4643&client=summon |